Revance Net Cash Flow or Change in Cash and Cash Equivalents from 2010 to 2024

RVNC Stock  USD 3.64  0.14  3.70%   
Check Revance financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revance main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.4 M, Interest Expense of 20.3 M or Total Revenue of 245.7 M, as well as many exotic indicators such as Price To Sales Ratio of 3.02, Dividend Yield of 0.0053 or Days Sales Outstanding of 41.0. Revance financial statements analysis is a perfect complement when working with Revance Valuation or Volatility modules.
  
This module can also supplement Revance's financial leverage analysis and stock options assessment as well as various Revance Technical models . Check out the analysis of Revance Correlation against competitors.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.

About Revance Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Revance income statement, its balance sheet, and the statement of cash flows. Revance investors use historical funamental indicators, such as Revance's Net Cash Flow or Change in Cash and Cash Equivalents, to determine how well the company is positioned to perform in the future. Although Revance investors may use each financial statement separately, they are all related. The changes in Revance's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Revance's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Revance Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Revance. Please read more on our technical analysis and fundamental analysis pages.
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Revance Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 495 people.

Currently Active Assets on Macroaxis

When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:
Check out the analysis of Revance Correlation against competitors.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Revance Stock analysis

When running Revance's price analysis, check to measure Revance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revance is operating at the current time. Most of Revance's value examination focuses on studying past and present price action to predict the probability of Revance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revance's price. Additionally, you may evaluate how the addition of Revance to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Revance's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.83)
Revenue Per Share
2.766
Quarterly Revenue Growth
0.398
Return On Assets
(0.26)
Return On Equity
(20.97)
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.